TABLE 2.
Tumor Location (any involvement) | No. of Patients | Patients w/Transient Speech Deficit (%) | Patients w/Persistent Deficit (%)* |
---|---|---|---|
Pars orbitalis | 14 | 2 (14.3) | 0 |
Pars triangularis | 30 | 12 (40.0) | 3/29 (10.3) |
Pars opercularis | 37 | 15 (40.5) | 4/35 (11.4) |
Any frontal operculum | 43 | 16 (37.2) | 4/41 (9.8) |
Two patients lost to follow-up.